-inc-logo-1200x675.png){kind=logo}
WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) fell 7% during mid-day trading on Thursday . The stock traded as low as $8.23 and last traded at $8.25. 9,615 shares were traded during mid-day trading, a decline of 87% from the average session volume of 75,649 shares. The stock had previously closed at $8.8740.
WuXi Biologics (Cayman) Price Performance
The company has a fifty day simple moving average of $8.67 and a 200-day simple moving average of $8.96.
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.
Featured Stories
- Five stocks we like better than WuXi Biologics (Cayman)
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
